Topics in xenobiochemistry: Receptor-dependent transcriptional activation of cytochrome P4503A genes: Induction mechanisms, species differences and interindividual variation in man

Xenobiotica

Volumn 32, Issue 3, 2002, Pages 165-206

  Gibson, G G ^a   Plant, N J ^a   Swales, K E ^a   Ayrton, A ^b   El Sankary, W ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CIMETIDINE; CLOTRIMAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DEXAMETHASONE; DIAZEPAM; ERYTHROMYCIN; FLUCONAZOLE; GESTODENE; GLUCOCORTICOID RECEPTOR; IFOSFAMIDE; IMIPRAMINE; ITRACONAZOLE; JOSAMYCIN; LANSOPRAZOLE; MEVINOLIN; MIDAZOLAM; NIFEDIPINE; PARACETAMOL; PREGNANE X RECEPTOR; QUINIDINE; RITONAVIR; SAQUINAVIR; SIMVASTATIN; TAMOXIFEN; UNINDEXED DRUG; VERAPAMIL; CYTOCHROME P450; DRUG RECEPTOR; ISOENZYME; N DEMETHYLASE; UNSPECIFIC MONOOXYGENASE;

DRUG METABOLISM; ENZYME MECHANISM; ENZYME STRUCTURE; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; MULTIGENE FAMILY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SPECIES DIFFERENCE; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYME SPECIFICITY; GENETICS; METABOLISM; TRANSACTIVATION;

STAPHYLOCOCCUS PHAGE 3A;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HUMANS; ISOENZYMES; OXIDOREDUCTASES, N-DEMETHYLATING; RECEPTORS, DRUG; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TRANS-ACTIVATION (GENETICS);

EID: 0036515846     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250110102674     Document Type: Review

References (183)

1. Cytochrome p450 hpcn3, a novel cytochrome p450 IIIA-gene product that is differentially expressed in adult human liver-cDNA and deduced amino-acid sequence and distinct specificities of cDNA-expressed hpcn1 and hpcn3 for the metabolism of steroid-hormones and cyclosporine
2. Inter-subject and doserelated variability after intravenous administration of erythromicin
3. A new orphan member of the nuclear hormone receptor family that interacts with a subset of retinoic acid response elements
4. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4
5. Steroid transport, accumulation and antagonism of P-glycoprotein in multidrug-resistant cells
6. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes
7. Gene regulation by steroid hormones
8. Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7
9. Identification of a human nuclear receptor defines a new signalling pathway for CYP3A induction
10. Mechanism of induction of cytochrome P450 enzymes by the proestrogenic endocrine disrupter pesticide-methoxychlor: Interactions of methoxychlor metabolites with the constitutive androstane receptor system
11. SXR, a novel steroid and xenobiotic-sensing nuclear receptor
12. The gene CYP3 encoding P450pcn1 (nifedipine oxidase) is tightly linked to the gene COL1A2 encoding collagen type 1 alpha on 7q21-q22. 1
13. Paradoxical transcriptional activation of rat-liver cytochrome-P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16-alpha-carbonitrile - Analysis by transient transfection into primary monolayer-cultures of adult-rat hepatocytes
14. Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family
15. Drug discovery and drug metabolism
16. A transcriptional regulatory element common to a large family of hepatic cytochrome P450 genes is afunctional binding site of the orphan receptor HNF-4
17. Catalysis of drug oxidation during embryogenesis in human hepatic tissues using imipramine as a model substrate
18. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR
19. The role of individual human cytochromes P450 in drug-metabolism and clinical-response
20. cDNA and deduced amino acid sequences of a dog liver cytochrome P450 of the IIIa gene sub-family
21. Nomenclature for human CYP2D6 alleles
22. Rifampicin treatment greatly increases the apparent oral clearance of quinidine
23. Cytochrome P450 3A - Ontogeny and drug disposition
24. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450
25. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue
26. Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: Role of the glucocorticoid and pregnane x receptors
27. Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers
28. Substrate-regulated, c-AMP-dependent phosphorylation, denaturation and degradation of glucocorticoid-inducible cytochrome P4503A1
29. The steroid and thyroid hormone receptor superfamily
30. Use of established hepatoma cell lines in biotoxicology
31. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons
32. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta
33. Isolation, heterologous expression and functional characterisation of a novel cytochrome P450 3A enzyme from a canine liver cDNA library
34. Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans
35. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2 and 3A3 in human hepatoma cells
36. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
37. Induction of CYP2C genes in human hepatocytes in primary culture
38. CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines
39. Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities
40. Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation
41. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
42. The orphan nuclear receptor hCAR supports constitutive expression of the human cytochrome P450 3A4 gene in HepG2 cells
43. Regioselective biotransformation of midazolam by members of the human cytochrome P4503A (CYP3A) subfamily
44. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for c/e bp and a novel liver-specific nuclear factor
45. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture
46. Cytochrome P450 3A4: Regulation and role in drug metabolism
47. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples
48. Bimodal distribution of renal cytochrome P450 3A activity in humans
49. CXR, a chicken xenobiotic-sensing orphan nuclear receptor is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR)
50. Gene structure of CYP3A4, and adult specific form of cytochrome P450 in human livers, and its transcriptional control
51. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis
52. A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR)
53. The nuclear orphan receptor CAR-retinoid x receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B6 gene
54. Co-induction of multiple hepatic cytochrome P-450 proteins and their messenger-RNAs in rats treated with imidazole antimycotic agents
55. Novel mutations of CYP3A4 in Chinese
56. Effect of age and gender on the activity of human hepatic CYP3A
57. Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression
58. Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors
59. Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif
60. The steroid hormone receptor superfamily: Molecular mechanisms of action
61. Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development
62. Interaction of methadone with substrates of human hepatic cytochrome P450
63. A novel form of mouse cytochrome P450 3A (Cyp3a-16): Its cDNA cloning and expression in fetal liver
64. Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in the 5′ flanking region
65. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene
66. Novel glucocorticoid receptor coactivator mechanisms
67. Sequence of the 5′-flanking region of CYP3A5 - Comparative-analysis with CYP3A4 and CYP3A7
68. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting
69. Phenobarbitone-responsive nuclear translocation of the receptor CAR in induction of the Cyp2b gene
70. Purification and properties of cytochrome P450 from homogenates of human fetal livers
71. An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway
72. Comparative-analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes
73. CYP3A gene-expression in human gut epithelium
74. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small-bowel enterocytes
75. Cytochrome P450 in human liver microsomes: High performance liquid chromatographic isolation of three forms and their characterisation
76. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1
77. Sequence diversity in CYP3A promoters and characterisation of the genetic basis of polymorphic CYP3A5 expression
78. Inductive and repressive effects of rifampicin on rabbit liver microsomal cytochrome P450
79. The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific
80. Pregnane X receptor: Molecular basis for species differences in CYP3A induction by xenobiotics
81. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
82. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
83. Substrates of human hepatic cytochrome P450 3A4
84. Mammalian hepatocyte differentiation requires the transcription factor HNF-4 alpha
85. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes
86. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small-bowel - Lack of prediction by the erythromycin breath test
87. Cyclosporin toxicity at therapeutic blood levels and cytochrome P4503A
88. Endocrine disrupting chemicals, phthalic acid and nonylphenol activate pregnane X receptor-mediated transcription
89. The expression of pregnane X receptor and its target gene, cytochrome P450 3a1, in perinatal mouse
90. Molecular mechanisms of genetic polymorphisms of drug metabolism
91. A gene structure of testosterone 6 betahydroxylase (P450IIIA)
92. Transcriptional elements directing a liverspecific expression of P450/6 beta A (CYP3A2) gene-encoding testosterone 6 beta-hydroxylase
93. Orphan nuclear receptors CAR and PXR share xenobiotic and steroid ligands
94. Xenobiotic induction of cytochrome P4502b1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (src-1) and the transcription factor sp1
95. The human intestinal epithelial cell line Caco-2: Pharmacological and pharmacokinetic applications
96. Induction of drug metabolism by nuclear receptor CAR: Molecular mechanisms and implications for drug research
97. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
98. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
99. A unified nomenclature system for the nuclear receptor superfamily
100. A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro
101. Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein A1 regulatory protein 1 and v-erba-related protein 3
102. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in cos-7 cells
103. Evaluation of the genetic component of variability in CYP3A4 activity: A repeated drug administration method
104. Characterisation of inter- and intra-intestinal differences in human CYP3A-mediated metabolism
105. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the by the steroid hormones transporter in L929 cells
106. Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene
107. Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: Synergistic increase of CYP3A4 induction by pregnane X receptor
108. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450 gene regulation
109. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes
110. Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans
111. Identification of a functional glucocorticoid response element in the CYP3A1/igc2 gene
112. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor
113. Transcriptional activation of human fetal cytochrome P450 CYP3A7
114. Control and statistical analysis of in vitro reporter gene assays
115. Effect of steroids on progesterone output by explants of human chorion
116. The role of heat shock proteins in regulating the function, folding and trafficking of the glucocorticoid receptor
117. CYP3A regulation: From pharmacology to nuclear receptors
118. A novel cisacting element in a liver cytochrome-P450 3A gene confers synergistic induction by glucocorticoids plus antiglucocorticoids
119. Modification of clinical presentation of prostate tumours by a novel genetic variant in CYP3A4
120. Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance
121. Transgenic mouse models of CYP3A4 regulation
122. A novel female-specific member of the CYP3A gene subfamily in the mouse liver
123. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
124. Molecular mechanisms of cytochrome P450 induction by xenobiotics: An expanded role for nuclear hormone receptors
125. Rabbit pregnane X receptor is activated by rifampicin
126. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnane X receptor to activate the CYP3A23 hormone response element
127. Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a non-classical receptor mechanism
128. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P450 3A in mice and humans
129. The glucocorticoid receptor is essential for induction of cytochrome P-450 2b by steroids but not for drug or steroid induction of cyp3a or P-450 reductase in mouse liver
130. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous-culture of human hepatocytes
131. Selective expression of cytochrome P450 CYP3A mRNA's in embryonic and adult human liver
132. Isolation of CYP3A5p cDNA from human liver - A reflection of a novel cytochrome P-450 pseudogene
133. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells
134. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals - Studies with liver microsomes of 30 Japanese and 30 Caucasians
135. Orphan receptor promiscuity in the induction of cytochromes P450 by xenobiotics
136. Human cytochrome P450s: Selectivity and measurement in vivo
137. Induction and drug development
138. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P450
139. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
140. Characterization of orphan nuclear receptor binding elements in sex-differentiated members of the CYP2C gene family expressed in rat liver
141. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene
142. Phenobarbitone response elements of cytochrome P450 genes and nuclear receptors
143. Molecular modelling of cytochrome P450 3A4
144. The hepatotoxicity of lithocholic acid in male mice
145. Effect of dexamethasone and phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: Changes during development
146. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinoneimine by human CYP3A4
147. Use of midazolam as a human cytochrome P4503A probe. 2. Characterization of interindividual and intraindividual hepatic CYP3A variability after liver-transplantation
148. Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, OATP-2
149. Determination of drug-metabolizing enzyme activity in vivo: Pharmacokinetic and statistical issues
150. Role reversal: New insights from new ligands for the xenobiotic receptor CAR
151. The xenobiotic compound 1,4-bis[3,5-dichloropyridyloxy)] benzene is an agonist ligand for the nuclear receptor CAR
152. Pharmacokinetic drug-interactions with rifampicin
153. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: Ethnic distribution and implications for prostate cancer risk
154. Hepatocyte-specific mutation establishes retionid X receptor as a heterodimeric integrator of multiple physiological processes in the liver
155. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4
156. Noninvasive tests of CYP3A enzymes
157. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P450
158. Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer-culture
159. The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity
160. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR and PPAR
161. Assessment of drug - Drug interactions: Concepts and approaches
162. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
163. Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5′-upstream regulatory region
164. Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43
165. Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans
166. Implications and consequences of enzyme induction on preclinical and clinical drug development
167. Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein
168. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid
169. Studies on the expression and metabolic capabilities of human liver cytochrome P45IIIA5 (hlp3)
170. Identification of a polymorphically expressed member of the human cytochrome P-450III family
171. The human CYP3A subfamily: Practical considerations
172. Isolation and characterisation of human liver fetal liver cytochrome P450HLp2: A third member of the P450III gene family
173. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR
174. Humanized xenobiotic response in mice expressing nuclear receptor SXR
175. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
176. Mouse liver cytochrome P450(P-450IIIAM1): Its cDNA cloning and inducibility by dexamethasone
177. 1
178. 1
179. Functional cytochrome P4503A isoforms in human embryonic tissues: Expression during organogenesis
180. The peptide near the C-terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver
181. Rat pregnane X receptor: Molecular cloning, tissue distribution and xenobiotic regulation
182. The in vitro hepatic metabolism of quinine in mice, rats and dogs: Comparison with human liver microsomes